Singapore markets close in 1 hour 3 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.54+0.37 (+3.64%)
At close: 4:00PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Cash flows from operating activities
Net income
-234,138
-227,278
-204,749
-178,840
-197,484
Depreciation & amortisation
2,954
2,847
2,044
1,513
1,531
Stock-based compensation
49,857
50,218
51,411
33,367
30,538
Change in working capital
-21,149
-13,008
29,233
-45,424
-5,419
Accounts receivable
-5,113
-1,971
24,773
-22,778
-39,914
Inventory
-1,358
-16,937
14,064
-29,122
-4,768
Accounts payable
-7,216
-2,233
-14,105
-1,906
11,955
Other working capital
-203,765
-191,633
-131,734
-200,976
-172,853
Other non-cash items
1,569
1,429
1,050
890
773
Net cash provided by operating activities
-199,538
-184,820
-124,580
-191,805
-170,300
Cash flows from investing activities
Investments in property, plant and equipment
-4,227
-6,813
-7,154
-9,171
-2,553
Purchases of investments
-129,138
-134,007
-477,035
-497,104
-121,570
Sales/maturities of investments
281,450
349,775
462,406
227,700
131,783
Net cash used for investing activities
148,085
208,955
-21,783
-278,550
7,738
Cash flows from financing activities
Debt repayment
-
0
0
-25,000
-25,000
Common stock issued
-
0
162,151
363,128
306,279
Net cash used provided by (used for) financing activities
161,898
9,105
186,425
357,608
293,731
Net change in cash
110,445
33,240
40,062
-112,747
131,169
Cash at beginning of period
80,728
71,898
31,836
144,583
13,414
Cash at end of period
191,173
105,138
71,898
31,836
144,583
Free cash flow
Operating cash flow
-199,538
-184,820
-124,580
-191,805
-170,300
Capital expenditure
-4,227
-6,813
-7,154
-9,171
-2,553
Free cash flow
-203,765
-191,633
-131,734
-200,976
-172,853